Does IBRUTINIB Cause Malignant neoplasm progression? 259 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 259 reports of Malignant neoplasm progression have been filed in association with IBRUTINIB (Imbruvica). This represents 0.3% of all adverse event reports for IBRUTINIB.
259
Reports of Malignant neoplasm progression with IBRUTINIB
0.3%
of all IBRUTINIB reports
98
Deaths
53
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IBRUTINIB?
Of the 259 reports, 98 (37.8%) resulted in death, 53 (20.5%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRUTINIB. However, 259 reports have been filed with the FAERS database.
What Other Side Effects Does IBRUTINIB Cause?
Death (8,007)
Off label use (5,446)
Fatigue (4,479)
Diarrhoea (3,903)
Atrial fibrillation (3,671)
Pneumonia (3,015)
Incorrect dose administered (2,752)
Contusion (2,712)
Fall (2,375)
Asthenia (2,200)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IBRUTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
IBRUTINIB vs IBUPROFEN
IBRUTINIB vs IBUPROFEN LYSINE
IBRUTINIB vs IBUPROFEN UNKNOWN PRODUCT
IBRUTINIB vs IBUPROFEN\IBUPROFEN
IBRUTINIB vs IBUPROFEN\PHENYLEPHRINE